Hem › Juvenil myelomonocyt leukemi › Washington
Kliniska studier för Juvenil myelomonocyt leukemi i Washington
3 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Seattle Children's Hospital, Seattle
RekryterarFas 1/2
1 Month – 21 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT05849662The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- och 1 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekryterarFas 1
Upp till ålder 80 · Alla kön · Uppdaterad 18 maj 2026 · NCT03326921Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.